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AbstrACt
Objectives To determine whether an association exists 
between delirium and length of time indwelling urine 
catheters (IUC) are used in octogenarian patients treated 
with surgical aortic valve treatment (SAVR) or transcatheter 
aortic valve implantation (TAVI).
Design Prospective cohort study.
setting Tertiary university hospital covering the western 
region of Norway.
Participants Octogenarian patients undergoing elective 
SAVR or TAVI and willing to participate in the study 
were eligible. Patients unable to speak Norwegian were 
excluded. Between 2011 and 2013, 143 consecutive 
patients were included, and data from 136 of them are 
presented.
Primary outcome Delirium.
results Logistic regression analysis shows that lower 
cognitive function was positively associated with 
delirium (OR 0.86, CI 0.74 to 0.99, p=0.047). Besides, 
the interaction term in the model shows that IUC use 
and delirium differed between SAVR and TAVI patients 
(p=0.04). The difference corresponded to a weaker 
association between hours of IUC use and delirium for 
SAVR (OR 1.01, CI: 0.99 to 1.03, p=0.54) compared with 
that for TAVI (OR 1.04, CI: 1.01 to 1.08, p=0.004).
Conclusions The association between IUC use and 
delirium is stronger for octogenarian patients treated with 
TAVI than for patients who received SAVR. Our results 
revealed a previously unknown association between the 
number of hours an IUC is used and postoperative delirium 
in octogenarian patients treated with TAVI.
IntrODuCtIOn 
Surgical aortic valve replacement (SAVR) 
and transcatheter aortic valve implanta-
tion (TAVI) are cardiac procedures often 
performed in patients 80 years old and older.1 
However, in this patient group the need for 
general anaesthesia, sternotomy and cardio-
pulmonary bypass—which is required with 
SAVR—might represent an excessive opera-
tive threat. TAVI is a minimally invasive treat-
ment option and the treatment of choice for 
patients who have a higher operative risk. 
TAVI is also a better choice for patients who 
are not suited for SAVR.2 3 
During cardiac procedures, monitoring 
of urine output may provide important clin-
ical information on haemodynamics. An 
indwelling urinary catheter (IUC) is typically 
used during SAVR, because haemodynamic 
and renal events associated with open-heart 
surgery are complex. The early adoption of 
surgical practices in TAVI programmes has 
resulted in use of IUCs in a similar way as 
that for SAVR, even though TAVI is a shorter 
procedure and has minimal clinical disrup-
tions.4 This raises questions about whether 
IUC use might be safely avoided, or greatly 
modified, for TAVI patients. Although prac-
tices continue to evolve, across many centres 
IUCs continue to be frequently used for TAVI, 
and IUC remains a standard of care for SAVR. 
However, IUC use does not come without 
challenges. It is associated with more hospital 
strengths and limitations of this study
 ► This is the first study aiming to identity possible dif-
ferences in the association between length of time 
of IUC use and delirium in octogenarian patients 
undergoing aortic valve therapy with SAVR or TAVI.
 ► The fact that very few patients declined consent to 
participation or went unidentified before treatment 
give us confidence that our study is robust against 
patient selection bias, and therefore, provides a 
sturdy foundation for policy guidance and direction 
for future studies.
 ► Despite having a relatively low number of included 
patients, the data from this study includes a geo-
graphical area covering a population of more than 
1 300 000, giving us confidence that our results 
reasonably reflect the octogenarian population of a 
large urban area in a modern western country.
 ► The results presented in this study are based on a 
secondary analysis of previously collected data of a 
completed observational study.
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complications, such as delirium and longer length of 
hospital stay and worse clinical outcomes.4 5
Postoperative delirium is a common hospital complica-
tion in older patients.6 Delirium is defined as an acute 
and fluctuating change in attention and cognition7 that 
can lead to functional and cognitive decline.8–10 The 
pathophysiology of delirium is not fully understood, but 
it has been established that a complex interrelationship 
between predisposing factors (age ≥75, cognitive and 
functional impairment, and comorbidities) and precipi-
tating factors (surgery, infections and physical restrains) 
contribute to its development.6
Delirium that emerges after SAVR and TAVI has been 
associated with undesirable outcomes in octogenarian 
patients.11–13 Previous studies show that IUC use might 
be linked to delirium in hospitalised medical patients 
70 years old and older.8 14–16 Urinary catheters have also 
been associated with a higher incidence of delirium in 
older hospitalised patients with cardiac diseases.17 Due to 
the less invasive nature of TAVI, the majority of patients 
receiving TAVI may require IUCs for shorter periods than 
patients receiving SAVR, or the practice may be re-exam-
ined with the increasing adoption of minimalist strategies. 
To the best of our knowledge, no study has investigated 
the use of IUCs and a possible association with delirium 
in octogenarian patients after SAVR or TAVI. The aim of 
the present study was therefore to determine whether an 
association exists between delirium and IUC use in octo-
genarian patients treated with SAVR or TAVI.
MethODs
study design, settings and participants
This study presents secondary analyses of data gathered 
in the Delirium in Octogenarians Undergoing Cardiac 
Surgery or Intervention (CARDELIR) study. CARDELIR is 
an observational, prospective cohort study of consecutive 
patients undergoing elective SAVR or TAVI in a tertiary 
university hospital. All SAVR and TAVI procedures in the 
western part of Norway are performed at this university 
hospital, which covers an extensive geographic area and 
a big population group.18 Inclusion criteria were: (1) age 
of 80 years and older, (2) previous acceptance for aortic 
valve treatment with SAVR or TAVI and (3) willingness to 
participate in the study. Exclusion criteria were inability 
to speak Norwegian or denied consent to participate. The 
presence or absence of delirium was the primary outcome 
of CARDELIR. A heart team comprised experts in cardio-
thoracic surgery and invasive cardiology evaluated octo-
genarian patients with aortic stenosis and identified those 
suited for SAVR or TAVI based on current guidelines at 
the time of the study.19 SAVR is an invasive procedure that 
requires general anaesthesia, sternotomy and extracorpo-
real circulation.20 TAVI was initially designed for high-risk 
patients, not suitable to SAVR.21 TAVI is less aggressive 
and can be performed without sternotomy or cardiopul-
monary bypass.20 21 A power analysis calculation for the 
original study showed that including 84 patients treated 
with SAVR and 65 patients receiving TAVI would give a 
power of 89% to detect delirium.18
Elective SAVR or TAVI was performed in 162 octoge-
narian patients between February 2011 and August 2013. 
Fifteen patients did not meet the inclusion criteria; three 
other patients were excluded, because we failed to iden-
tify them before surgery or intervention due to adminis-
trative reasons. This left a total of 144 patients who agreed 
to participate in CARDELIR; however, one of them with-
drew consent before treatment, and seven more could 
not be assessed for delirium because they were non-re-
sponsive after surgery or had died. Accordingly, this study 
presents data for 136 patients, 63 (46%) of them were 
treated with TAVI. A patient was classified as having expe-
rienced delirium if delirium had been identified at least 
once between the first and fifth postoperative day.
Variables
Delirium
The presence/absence of delirium was identified with 
the Confusion Assessment Method (CAM).22 CAM is 
an instrument based on the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV) that captures the 
four core features of delirium, which include (1) acute 
onset and fluctuating course, (2) inattention, (3) disor-
ganised thinking and (4) altered level of consciousness. 
The presence of delirium is established when features (1) 
and (2) are present, and either (3) or (4) are displayed.22
Duration of IUC use
The IUC was inserted immediately prior to SAVR or TAVI, 
and information about the length of time (in hours) a 
patient had an IUC was retrieved from medical records.
Other relevant variables
Cognitive function
The Mini-Mental State Examination was used to evaluate 
baseline general cognitive functioning of patients.23 This 
instrument produces a score between 0–30 points, with 30 
indicating the highest level of cognition.23
Functional independence
The functional independence of patients was evaluated 
with the Barthel Index. This index assesses self-care 
abilities in feeding, bathing, grooming, dressing, bowel, 
bladder, toilet use, transferring, walking, and using stairs.24 
The highest achievable score on the index is 20, with a 
score of 19 representing functional independence.24
Comorbidities
Preoperative comorbidities were quantified with the 
Charlson Comorbidity Index.25 This index predicts 
mortality by assigning values to different comorbidity 
disorders, and by adding up the values to produce a sum 
score. Higher scores represent higher risk of mortality.25
Other potential factors associated with the develop-
ment of delirium (atrial fibrillation and infections) were 
based on literature review6 26 and on clinical experience.
 on 4 N
ovem









pen: first published as 10.1136/bm






3Eide LSP, et al. BMJ Open 2018;8:e021708. doi:10.1136/bmjopen-2018-021708
Open access
Data collection
A detailed description of preoperative data collection 
and assessment of delirium has been presented earlier.18 
In short, patients fulfilling the inclusion criteria were 
approached the day before SAVR or TAVI, and informed 
consent was obtained. Experienced members of the 
research team performed assessment of cognitive func-
tion and functional independence after inclusion. 
Medical records and interviews with patients provided 
demographic information and clinical data.
Delirium was assessed from the first to the fifth post-
operative day at approximately the same time of the 
day (noon). To strengthen inter-rater reliability, only 
members of the research team having several years of 
experience with cardiac and geriatric patients, and 
trained in the use of CAM, performed the delirium 
assessment. Nursing staff at the cardiothoracic surgery 
department received information about the features 
of delirium on a regular basis and were encouraged 
to report delirium symptoms at every shift. Medical, 
nursing, and physiotherapy reports from the previous 
24 hours and results from meetings with health profes-
sionals caring for the patients were also considered 
when the CAM was scored.
Patients undergoing SAVR or TAVI received prophy-
lactic antibiotics following an identical regimen. Ceph-
alosporin (Cefalotin) was administered every 90 min 
during the procedure. Treatment continued during the 
first postoperative day every 6 hours, with a maximum of 
five doses.
All participants had an IUC inserted immediately prior 
to the start of the SAVR or TAVI procedure. Hospital 
protocols prescribe IUC removal within 24 hours after 
surgery for clinically stable patients treated with SAVR, 
whereas protocols for clinically stable patients treated 
with TAVI prescribe the removal of the IUC the same day 
the procedure is performed.
statistical methods
Data are presented as counts and percentages, or means 
and SD/CI. Pearson’s χ2 test was used to compare 
treatment groups (SAVR vs TAVI and Delirium vs 
non-delirium) and categorical variables. Comparisons 
between treatment groups and continuous variables 
were performed using Welch’s t-test (a t-test that does 
not assume equal variances across groups). The associa-
tion between risk factors for delirium (including length 
of time of IUC use) in patients following aortic valve 
replacement was evaluated with logistic regression. The 
logistic model also included an interaction term between 
type of aortic valve treatment (SAVR/TAVI) and length 
of time of IUC use. This allowed us to examine whether 
the association between length of time of IUC use and 
delirium differed between the two treatment types. Data 
management and statistical analyses were performed in 
SPSS (IBM SPSS Statistics for Windows, V.24.0) and R 
V.3.4.0.27
ethical considerations
The study was conducted in accordance with the Decla-
ration of Helsinki. Special consideration was given to 
behavioural indicators of patient exhaustion during 
data collection. Whenever these signs were present, data 
collection was stopped and resumed later.
Patient and public involvement
No patients were involved in the design or implementa-
tion of this study. However, CARDELIR has provided data 
for several quantitative18 28 29 and qualitative studies30 31 
having patient-reported outcomes. The results of these 
papers have been extended to the patient community 
through patient organisations and open lectures.
results
Characteristics of the study population and development of 
delirium
The majority (56%) of patients were females, and 46% of 
the cohort received TAVI. Patients in the TAVI group were 
older (85 vs 82 years old, p<0.001); had more comorbid-
ities (2.5 vs 1.8, p=0.001); and had higher logistic Euro-
SCOREs (19.6 vs 9.4, p<0.001). Table 1 summarises other 
characteristics of the participants, stratified by SAVR or 
TAVI.
New episodes of delirium occurred at least once in 
56% of the octogenarian patients during the 5-day study 
period. Of the patients in the SAVR group, 66% devel-
oped delirium compared with 44% of patients in the TAVI 
group (p=0.01), but the average number of days patients 
experienced delirium did not differ significantly between 
SAVR and TAVI patients (p=0.20).18
Aortic valve treatment type, duration of IuC use and delirium
The average duration of IUC use in the total sample 
was 54 hours (SD 31, range 18–120 hours). On average, 
patients with delirium used an IUC for 63 hours (SD=33), 
whereas patients without delirium used an IUC for 
43 hours (SD=25) (p<0.001).
The length of time of IUC use in SAVR patients with 
delirium was, on average, 66 hours (SD=29), compared 
with 59 hours (SD=27) for SAVR patients without delirium 
(p=0.31). The length of time of IUC use in patients treated 
with TAVI and with delirium was, on average, 58.5 hours 
(SD 38.2), while TAVI patients without delirium used an 
IUC, on average, 31.6 hours (SD=15.1; p=0.001) (table 2).
Interaction analysis
The logistic regression model that included an inter-
action term (SAVR/TAVI ×length of time of IUC use) 
showed a significant association with lower cognitive 
scores (MMSE) (OR 0.86, CI: 0.74 to 0.99, p=0.047), and 
a significant interaction between length of time of IUC 
use and treatment type (p=0.003). This interaction corre-
sponds to an association between hours of IUC use and 
delirium of OR 1.04 (CI: 1.00 to 1.08, p=0.04) for TAVI 
(table 3 and figure 1).
 on 4 N
ovem









pen: first published as 10.1136/bm






4 Eide LSP, et al. BMJ Open 2018;8:e021708. doi:10.1136/bmjopen-2018-021708
Open access 
DIsCussIOn
To the best of our knowledge, this is the first study that 
shows an association between length of time an IUC is 
used and incidence of delirium in octogenarian patients 
treated with TAVI. Our main findings were that patients 
with delirium had used an IUC for a significantly longer 
time than patients without delirium, and that the asso-
ciation between IUC use was stronger for TAVI patients 
than for SAVR patients (figure 1). Our results are clini-
cally relevant, considering the increasing number of octo-
genarian patients receiving advanced cardiac procedures 
such as SAVR and TAVI. Moreover, these findings should 
Table 1 Characteristics of octogenarian patients undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic 
valve implantation (TAVI) (n=136)
Variables








Age (years), mean SD 83.5±2.7 82±2.1 85±2.8 <0.001
Female n (%) 76 (55.9) 36 (49.3) 40 (63.5) 0.09
MMSE, mean SD (range 0–30) 27.2±2.9 27.8±2.6 26.5±3.1 0.01
Charlson Comorbidity Index, mean 
SD
2.1±1.2 1.8±0.9 2.4±1.3 0.01
Logistic EuroScore 14.0±9.2 9.2±3.4 19.6±10.6 <0.001
NYHA functional class <0.001
  I+II (%) 47 (34.6) 37 (54.4) 10 (18.5)
  III+IV (%) 75 (55.1) 31 (45.6) 44 (81.5)
LVEF (%) 56.6±10.2 57.2±10.3 55.8±10.2 0.41
Max aorta gradient (mm Hg) 79.5±23.9 83.5±24.7 75±22.4 0.04
Mean aorta gradient (mm Hg) 48.3±16.1 50.7±16.3 46±15.8 0.08
ASA Classification <0.001
  III (yes) 114 (83.8) 71 (97.3) 43 (68.3)
  IV (yes) 22 (16.2) 2 (2.7) 20 (31.7)
Delirium (yes) 76 (55.9) 48 (65.8) 28 (44.4) 0.01
ASA, American Society of Anesthesiologist Physical Status Classification System; BMI, body mass index; IADL, instrumental activities of 
daily living; LVEF, Left ventricle ejection fraction; MMSE, Mini Mental State Examination; NYHA, New York Heart Association Functional 
Classification.

























mean ±SD or 
(percentage) 
Age (years), mean SD 83.5±2.7 81.6±1.4 82.7±2.3 0.01 84.7±2.8 84.9±2.8 0.74
Female, n (%) 76 (55.9) 12 (48) 24 (50) 0.87 25 (71.4) 15 (53.6) 0.14
Barthel Index, mean SD 
(range 0–20)
18.9±1.5 19.5±1.0 18.9±1.5 0.06 18.9±1.5 18.5±1.4 0.28
MMSE, mean SD (range 
0–30)
27.2±2.9 27.9±2.2 27.8±2.8 0.86 27.4±2.4 25.4±3.6 0.01
Charlson Comorbidity 
Index, mean± SD
2.1±1.2 1.8±1.0 1.8±0.9 0.78 2.3±1.3 2.7±1.3 0.20
Infections (yes), n (%) 48 (35.3) 5 (20) 15 (31.3) 0.30 13 (37.1) 15 (53.6) 0.19
Length of time of IUC use 
(hours), mean SD
54±31 59±27 66.1±29.3 0.31 31.6±15.1 58.5±38.2 0.001
IUC use, Indwelling urine catheter use; MMSE, Mini Mental State Examination; SAVR, Surgical aortic valve replacement; TAVI, 
transcatheter aortic valve implantation.
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give new guidance for policy that will allow hospitals to 
provide better healthcare to the complex group that geri-
atric patients represent.32
The present study has several aspects that contribute 
positively to clinical knowledge on the association 
between delirium and length of time IUC is used among 
octogenarian patients treated with SAVR or TAVI. Among 
the strengths of the study is the inclusion of consecu-
tively admitted octogenarian patients undergoing aortic 
valve treatment. Very few patients declined consent to 
Table 3 Logistic regression model showing interaction effect between type of treatment and length of IUC use (hours) on 
postoperative delirium (n=136)
Unadjusted Adjusted
OR 95% CI P values OR 95% CI P values
Gender 0.23 0.84
  Male (ref.)
  Female 0.66 0.33 to 1.30 0.92 0.41 to 2.10
Barthel Index (range 0–20) 0.82 0.63 to 1.04 0.10 0.74 0.54 to 1.00 0.06
Atrial fibrillation 0.22 0.11
  No (ref.)
  Yes 1.61 0.76 to 3.53 2.18 0.86 to 5.83
Charlson Comorbidity Index 1.02 0.76 to 1.37 0.91 1.03 0.73 to 1.48 0.86
MMSE score 0.92 0.81 to 1.03 0.15 0.86 0.74 to 0.99 0.05
Length IUC use (hours) 1.013 1.01 to 1.04 <0.001 1.01 0.99 to 1.03 0.54
Postoperative infections 0.25 0.27
  No (ref.)
  Yes 1.52 0.75 to 3.16 1.63 0.68 to 4.03
Treatment 0.01 0.003
SAVR (ref.)
TAVI 0.42 0.21 to 0.83 0.06 0.01 to 0.35
Length IUC use (hours)×treatment type – 1.04 1.00 to 1.08 0.04
IUC use, Indwelling urine catheter use; MMSE, Mini Mental State Examination; ref, reference; SAVR, Surgical aortic valve replacement; TAVI, 
transcatheter aortic valve implantation.
Figure 1 Estimated ORs (with 95% point-wise CI) for the association between postoperative delirium (response) and surgery 
type and hours of indwelling urinary catheter use (explanatory variables) for octogenarian patients undergoing surgical aortic 
valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI). The reference level has been set to SAVR and 
48 hours (the median number of hours of IUC use in the whole population) (n=136).
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participation (6%), and fewer than 2% of the consecu-
tive series of patients went unidentified before treatment. 
These aspects give us confidence that our study is robust 
against patient selection bias, and therefore, provides a 
sturdy foundation for policy guidance and direction for 
future studies. We are also confident that our objective 
assessment of delirium was reasonable. Patients’ delirium 
was measured using a well-accepted, valid and reliable 
instrument,22 and it was performed by experienced 
research team members having several years of care expe-
rience with geriatric and cardiac patients. We believe that 
our results reasonably reflect the old population of a large 
urban area in a modern western country. Despite having 
a relatively low number of included patients, the data 
from this study is based on a geographical area covering a 
population of more than 1 300 000.18
However, our findings should be interpreted with 
caution due to several limitations. First, the present 
results are based on a secondary analysis of previously 
collected data of a completed observational study that 
was not a randomised controlled trial (RCT). Thus, all 
general caveats relevant to a non-RCT apply here also. 
This being said, randomisation was not possible in the 
original study, because SAVR and TAVI are used to treat 
different patient populations,33 and it would be uneth-
ical to randomise this factor. Even though we did our 
best to identify confounding factors, as always, unknown 
confounding factors could have also influenced our 
results. Despite recent advances in delirium, its patho-
physiology remains to be fully understood, and the use 
of IUCs in octogenarian patients might only represent 
an additional piece in the delirium ‘puzzle’. Our modest 
sample size and power considerations limited the number 
of variables we could include in the regression analysis, 
representing a limitation of our study.
Surgical procedures, such as SAVR, demand closer 
monitoring of patients’ urine output during the oper-
ative and postoperative phase. However, unnecessary 
and prolonged use of IUCs can lead to undesirable 
effects. Bladder catheters, for example, have been linked 
to delirium in hospitalised patients 70 years old and 
older.8 14 16 As shown in table 2, SAVR patients who later 
developed delirium used IUCs on average 8 hours longer 
than TAVI patients who also developed the condition. Yet, 
on further analysis, we revealed a previously unknown 
association between the number of hours an IUC is 
used and delirium in octogenarian patients treated with 
TAVI. This association shows an estimated 4% increased 
odds for delirium for each hour TAVI patients had used 
an IUC, compared with 1% increased odds for SAVR 
patients. This suggests that patients treated with TAVI and 
without complications, possibly could benefit if they used 
an IUC for a shorter periods of time4 or from the avoid-
ance of this device.34
It has been postulated that delirium emerges as a 
consequence of (1) definable major events, and (2) an 
abnormal response to different stressors.35 SAVR might 
be an example of a major event that can eventually lead 
to delirium. SAVR demands general anaesthesia, ster-
notomy and extracorporeal circulation. These proce-
dures might contribute to an excessive strain in a group 
of octogenarian patients. In other cases, delirium might 
be activated by an abnormal reaction to a minor event.35 
Unnecessary or extended use of an IUC might be an 
example of a minor event. Octogenarian patients in the 
TAVI group had several baseline risk factors for delirium 
(older, more comorbidities, lower cognitive scores) that, 
together with the prolonged use of IUCs, might have 
triggered delirium. Yet, the invasive nature of SAVR 
compared with TAVI could even up these risk factors. It 
should be mentioned that in our patient group, delirium 
could emerge both before and after IUC removal. Taking 
this into consideration, further analyses of preoperative 
biomarkers of stress, such as cortisol, in patients treated 
with SAVR and TAVI could provide valuable information.
IUC use might contribute to, or sustain, already 
elevated postoperative inflammation. The role that 
inflammation plays in the development of delirium has 
been highlighted in recent years.36 A study with TAVI 
patients found that avoidance of IUC use was associated 
with significantly lower rates of urinary tract infections 
requiring antibiotics, haematuria and bladder irrigation.4 
Even when IUC implantation was less than 24 hours, this 
study found negative outcomes in patients using IUC.4 
Even though completely avoiding the use of an IUC is 
currently not possible in patients treated with SAVR, 
further studies should evaluate whether the length of 
time an IUC is used could be reduced in clinically stable 
SAVR patients after the procedure is performed. Studies 
should also evaluate whether IUC use could be avoided 
entirely in TAVI patients.
Infections can precipitate delirium,6 and the use of an 
IUC has been linked to urinary tract infections.37 Our 
results show that patients with delirium, independent of 
SAVR or TAVI treatment, used an IUC for longer than 
2 days. However, no association between infections and 
delirium was identified with either univariate or multivar-
iate regression analysis (tables 2 and 3). This suggests that 
when delirium was present in our octogenarian patients, 
the concurrent presence of an infection cannot explain 
the emergence of delirium.
Guidelines in the prevention and treatment of post-
operative delirium recommend patient mobility and 
avoidance of physical restrains.36 In some cases, patient 
mobility can be compromised when healthcare institu-
tions intent to prevent falls.38 Physical restraints are also 
linked to the emergence of delirium in intensive care 
units.6 In SAVR and TAVI patients, IUCs and cardiac 
monitoring devices keep patients from moving freely. 
However, it is interesting to see that the association 
between length of use of IUC and delirium is weaker in 
SAVR patients. As previously mentioned, when compared 
with TAVI, patients treated with SAVR had several factors 
that could compromise mobility even further: cardiac 
monitoring devices, central venous catheter, IV lines and 
oxygen masks. Besides, the invasive nature of the surgery 
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might limit mobilisation in a stronger way than in octo-
genarians undergoing TAVI.
In conclusion, the length of time an IUC is used is 
positively correlated with postoperative delirium in octo-
genarian patients with severe aortic stenosis and treated 
with TAVI. Additional studies with similar populations 
are required to identify all the variables connected to 
the emergence of delirium in older cardiac patients, 
including what comprises minor and major events that 
precipitate this abnormal response to stressors.
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